World OTC Pharmaceutical Market Forecast 2016-2026

OTC医薬品(市販薬)の世界市場予測2016-2026

◆タイトル:World OTC Pharmaceutical Market Forecast 2016-2026
◆商品コード:VGAIN6041529
◆調査・発行会社:visiongain
◆発行日:2016年3月
◆ページ数:247
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名利用)GBP1,999 ⇒換算¥303,848見積依頼/購入/質問フォーム
Five UserGBP2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Site License(全社内共有可)GBP4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"OTC医薬品(市販薬)の世界市場予測2016-2026"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、主要企業分析、結論などの情報をお届けいたします。

What can be expected from the Over-the-Counter Pharmaceuticals Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
Our 247-page report provides 148 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across the all the major categories of over-the-counter medicines market. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis) and commercial developments.

See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following Over-the-Counter Pharmaceuticals submarkets:
• Analgesics
• Cough, Cold and Allergy
• Gastrointestinal
• Dermatological
• Eye Care
• Smoking Cessation Aids
• Other Products (grouped category).

See detailed profiles or revenue forecasts for some the leading drugs in the market
How will leading drug perform to 2026? Our study provides detailed forecasts revenues for a number of leading drugs in the over-the-counter medicine market including:
• Voltaren
• Bayer Aspirin

Profiles are also included for the following:
• Panadol
• Alli
• Flonase Allergy Relief
• Claritin
• Tylenol
• Rhinocort Allergy
• Nicorette
• Nexium
• Advil
• Prilosec OTC
• Mucinex
• Nasacort
• Allegra
• Clarinex

See revenue forecasts for the leading international markets
How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets including products, including:
• US
• EU5 – Germany, UK, France, Italy and Spain
• China
• Japan
• India
• Russia
• Brazil
• Mexico

Leading companies and potential for market growth
Visiongain forecasts overall revenue for the Over-the-Counter Pharmaceuticals Market will exceed $127bn in 2016. We predict revenue growth higher than the rate of the total pharmaceutical market through to 2026. Advances in mHealth, a more liberal regulatory landscape, strong support from governments in multiple regions to meet the growing demands of an ageing increasing population and the launch of several new therapies in areas for chronic conditions will drive sales to 2026.

Our work analyses the key companies in the market. See visiongain’s analysis of nine leading companies, including these:
• GSK Consumer Health (JV with Novartis)
• Bayer
• Johnson and Johnson
• Perrigo
• Pfizer
• Procter & Gamble
• Reckitt Benckiser
• Sanofi
• Boehringer Ingelheim

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Historic revenue, analysis and discussion of company performance
• Analysis of major products currently on the market
• Acquisitions and strategic partnerships

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the over-the-counter medicines industry?
Our new report discusses issues and events affecting the over-the-counter medicines medicine market. You will find discussions, including qualitative analyses:
• Highly fragmented and competitive market with significant variations in different geographic regions
• Changing political and regulatory landscape changing the prospects of future successful OTC switches
• Significant company M&A activity changing the competitive landscape of the whole market

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

【レポートの目次】

1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 OTC Pharmaceuticals Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals
2.1 What Are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How Is a Drug Switched from Prescription to OTC?
2.5 Manufacturing and Distribution of OTC Pharmaceuticals
2.6 Regulation of OTC Pharmaceuticals
2.6.1 Regulation of OTC Pharmaceuticals in the US
2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.6.3 Regulation of OTC Pharmaceuticals in Europe
2.6.4 Regulation of OTC Pharmaceuticals in China
2.6.5 Regulation of OTC Pharmaceuticals in Others Countries
2.7 OTC Pharmaceuticals: Market Segmentation
2.7.1 Analgesics
2.7.1.1 Internal Analgesics
2.7.1.2 External Analgesics
2.7.2 Cough, Cold and Allergy Products
2.7.2.1 Cough and Cold Remedies
2.7.2.2 Anti-Allergy Products
2.7.3 Dermatological Products
2.7.3.1 Minor Cuts and Wounds
2.7.3.2 Acne
2.7.3.3 Rashes, Itchy Skin, and Dermatitis/Eczema
2.7.3.4 Cold Sores
2.7.3.5 Warts
2.7.3.6 Fungal Skin Infections
2.7.3.7 Haemorrhoids
2.7.3.8 Other Dermatological Products
2.7.4 Gastrointestinal Products
2.7.4.1 Indigestion and Heartburn
2.7.4.2 Anti-Diarrhoea OTC Pharmaceuticals
2.7.4.3 Laxatives
2.7.4.4 Anti-Emetic OTC Pharmaceuticals
2.7.4.5 Anti-Obesity OTC Pharmaceuticals
2.7.5 Eye Care
2.7.5.1 Dry Eye Syndrome
2.7.5.2 Bacterial Conjunctivitis
2.7.5.3 Ocular Allergy and Allergic Conjunctivitis
2.7.5.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
2.7.6 Smoking Cessation Aids
2.7.7 Other OTC Products
2.7.8 Vitamins, Minerals and Supplements
3. The World OTC Pharmaceutical Market 2016-2026
3.1 The World OTC Pharma Market in 2014 and 2015
3.1.1 OTC Pharma Market Segmentation in 2015 and 2016
3.1.2 Leading OTC Pharma Brands
3.1.3 Leading Companies in the OTC Market in 2014 and 2015
3.2 The World OTC Pharma Market: Sales Forecast 2016-2026
3.2.1 The World OTC Pharma Market, 2016-2026: Drivers and Restraints
3.3 OTC Pharma Market Segments: Sales Forecasts, 2016-2026
3.3.1 CAGRs by OTC Segment, 2015-2025
3.3.2 Changing Market Shares by OTC Segment, 2016-2026
3.3.3 Cough, Cold and Allergy OTC Market: Sales Forecast 2016-2026
3.3.4 Analgesics OTC Market: Sales Forecast 2016-2026
3.3.5 Gastrointestinal OTC Market: Sales Forecast 2016-2026
3.3.6 Dermatological OTC Market: Sales Forecast 2016-2026
3.3.7 Eye Care OTC Market: Sales Forecast 2016-2026
3.3.8 Smoking Cessation OTC Market: Sales Forecast 2014-2026
3.3.9 Other OTC Market: Sales Forecast 2016-2026

4. The Leading National Markets 2016-2026
4.1 Regional Breakdown of the World OTC Pharma Market in 2014 and 2015
4.2 The World OTC Pharmaceutical Market: Regional Forecast 2016-2026
4.3 Changing Market Shares of Leading National Markets: Emerging Dominance of China
4.4 The US OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.4.1 The US OTC Pharma Market: Financial Incentives to Using OTC Drugs
4.4.2The US OTC Pharma Market: Leading Companies
4.5 The Japanese OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.5.1 The Japanese OTC Pharma Market: Deregulation could Stimulate Growth
4.5.2The Japanese OTC Pharma Market: Leading Companies
4.6 The EU5 OTC Pharma Market in 2014 and 2015
4.6.1 Changing Market Shares of the EU5 OTC Pharmaceuticals Market
4.6.2 The EU5 OTC Market Sales Forecast, 2016-2026
4.6.3 The EU5 OTC Pharma Market: Leading Companies
4.6.4 The German OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.5 The UK OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.5.1 The UK’s Liberal OTC Regulations
4.6.6 The French OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.6.6.1 OTC Drugs: A French Monopoly System
4.6.7 The Italian OTC Pharmaceutical Market Sales Forecast, 2015-2025
4.6.8 The Spanish OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7 The Chinese OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.7.1 The Chinese OTC Pharma Market: Leading Companies
4.7.2 The Role of Traditional Chinese Medicines (TCM) in the Chinese OTC Market
4.8 The Brazilian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.8.1 The Brazilian OTC Pharma Market: An Overview
4.9 The Russian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.9.1 The Russian OTC Pharma Market: Overview
4.10 The Indian OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.10.1 The Indian OTC Pharma Market: An Overview
4.11 The Mexican OTC Pharmaceutical Market Sales Forecast, 2016-2026
4.12 The Rest of the World OTC Pharmaceutical Market Sales Forecast, 2016-2026

5. Leading Companies in the OTC Pharma Market 2016-2026
5.1 Leading OTC Pharmaceutical Manufacturers, 2015
5.1.1 Leading OTC Pharmaceutical Manufacturers after completed Transactions, 2015
5.2 GSK
5.2.1 GSK Consumer Healthcare Unit: Historical Activity
5.2.2 GSK Consumer Healthcare Formed by a Joint-Venture Undertaken by GSK and Novartis
5.2.3 GSK/Novartis: Additional Transactions
5.2.4 GSK Consumer Healthcare: OTC Sales Forecast, 2015-2026
5.2.5 Flonase Launched in US
5.2.6 Panadol
5.2.7 Voltaren Gel
5.2.7.1 Voltaren Gel: Sales Forecast 2015-2025
5.2.8 Alli: A Beleaguered Brand
5.2.9 GSK Smoking Cessation Products
5.3 Novartis (OTC Joint Venture with GSK)
5.3.1 Novartis: Transformational Year
5.4 Bayer
5.4.1 Acquisition of Merck’s Consumer Care Business, 2014
5.4.2 Bayer Acquires Dihon in 2014
5.4.3 Bayer: OTC Sales Forecast, 2014-2025
5.4.4 Bayer Aspirin
5.4.5 Bayer Aspirin: Sales Forecast 2016-2026
5.4.6 Claritin OTC (Loratadine)
5.5 Merck & Co (Consumer Care Segment Acquired by Bayer)
5.6 Johnson and Johnson
5.6.1 FDA Governance of McNeil Manufacturing Activity
5.6.2 Johnson & Johnson: OTC Sales Forecast, 2014-2026
5.6.3 Rhinocort Allergy Spray
5.6.4 Tylenol
5.6.5 Nicorette
5.7 Perrigo
5.7.1 Perrigo: OTC Sales Forecast, 2014-2026
5.7.2 Perrigo Benefits from Challenges Faced by J&J
5.7.3 Perrigo: Growth by Acquisition
5.7.4 Perrigo Acquires Omega Pharma
5.7.5 Perrigo Acquires GSK Portfolio
5.7.6 Perrigo Expands Mexican Capacity and Capabilities
5.7.7 Mylan’s Hostile Takeover Bid
5.8 Pfizer
5.8.1 Pfizer: OTC Sales Forecast, 2015-2025
5.8.2 Pfizer Announces Merger with Allergan
5.8.3 Pfizer Acquires Rights to AstraZeneca’s OTC Nexium
5.8.4 Pfizer: Bulking up Their OTC Product Portfolio
5.8.5 Advil
5.9 Procter & Gamble
5.9.1 PGT Healthcare- Procter& Gamble’s Joint Venture with Teva
5.9.2 Prilosec OTC
5.9.3 Major Plans for Divestment Including OTC Products
5.10 Reckitt Benckiser
5.10.1 Reckitt Benckiser: OTC Sales Forecast, 2014-2026
5.10.2 Internal Growth by “Power” Brand Extensions: Mucinex
5.10.3 Expanding Presence in Emerging Markets through Acquisition
5.11 Sanofi
5.11.1 Sanofi Focuses on Long-Term Growth with Potential Boehringer Ingelheim Asset Swap Pending Completion Q4 2016
5.11.2 Sanofi: Acquisition of OTC Products from J&J
5.11.3 Sanofi: Launch of Nasacort
5.11.4 Sanofi: OTC Sales Forecast, 2014-2026
5.12 Boehringer Ingelheim
5.12.1 Boehringher Ingelhime: OTC Sales Forecast 2014-2026
5.13. Mylan Enter OTC Market

6. OTC Switching and Potential Future of OTC Drugs
6.1 OTC Switching: An Overview
6.1.1 What is OTC Switching?
6.1.2 Which Products Will Switch?
6.1.3 How Does OTC Switching Occur?
6.1.4 How Does OTC Switching Affect the OTC Pharma Market?
6.1.5 Opposition to OTC Switching
6.2 OTC Switching Activity, 2002-2015
6.2.1 OTC Switching: Downward Trend
6.2.2 The FDA NSURE Initiative: Reversing the Downward Trend in Rx-to-OTC Switches
6.3 Potential Candidates for OTC Switching 2016-2026
6.4 Cough, Cold and Allergy: OTC Switches
6.4.1 First-Generation Antihistamines
6.4.2 Allegra (fexofenadine)
6.4.3 Clarinex (desloratadine)
6.4.4 Rhinocort Allergy Spray (budesonide): Latest Nasal Corticosteroid Approval
6.4.5 Flixotide/Flonase (fluticasone): Latest Nasal Corticosteroid Approval
6.4.6 Nasacort (triamcinolone): First in Class U.S. OTC Approval
6.5 Analgesics: OTC Switch Limitations
6.5.1 Triptans: The U.S. Will Remain Cautious
6.5.2 NSAIDs for Arthritis: Safety Concerns Incites Reverse-Switching
6.5.3 Other Analgesics
6.6 Gastrointestinals: OTC Switches
6.6.1 H2-Receptor Blockers
6.6.2 Proton Pump Inhibitors (PPIs)
6.6.2.1 Omeprazole
6.6.2.2 Lansoprazole
6.6.2.3 Pantoprazole
6.6.2.4 Esomeprazole: 2014 U.S. FDA Approval for OTC Use
6.6.2.5 Rabeprazole
6.6.3 Anti-Obesity Drugs
6.7 Dermatologicals: OTC Switches
6.7.1 Antivirals for Oral Herpes Simplex
6.8 Anticholinergics for Incontinence: OTC Switches
6.9 Oral Contraceptives: An OTC Switch Can have Significant Economic Benefits
6.10 High Demand for OTC Cholesterol-Lowering Drugs
6.10.1 Lipitor (atorvastatin): Testing Times for Pfizer
6.10.2 Zocor Heart Pro (simvastatin) in the UK
6.10.3 OTC Statins: U.S. Historical Setbacks
6.11 Other Potential OTC Switch Categories
6.11.1 High Blood Pressure: Thiaside Diuretics
6.11.2 Erectile Dysfunction: Viagra (sildenafil), Cialis (tadalafil)
6.11.3 Osteoporosis: (Bisphosphonates) An Undertreated Disease, but a Very Unlikely OTC Switch
6.11.4 Insomnia: Silenor (doxepin)

7. Qualitative Analysis of the OTC Pharma Market, 2016-2026
7.1 SWOT Analysis of the OTC Pharmaceutical Market
7.2 Strengths
7.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
7.2.1.1 Manufacturers Can Reap OTC Sales Benefits
7.2.1.2 Third Party Payers: Reducing the Cost Burden
7.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
7.2.2 Many Pharma Companies Have a Strong Potential OTC Portfolio
7.2.3 Regulators Are Encouraging OTC Approvals
7.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
7.2.5 Deterring the Consumption of Counterfeit Drugs
7.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
7.3 Weaknesses
7.3.1 Pharma Companies Remain Focused on Prescription Drugs
7.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
7.3.3 OTC Products are Vulnerable to Price Controls by Governments
7.3.4 Downward Cost Pressures of OTC Drugs
7.4 Opportunities
7.4.1 Demographic and Economic Changes Will Create Growth Opportunities
7.4.2 New OTC Switch Categories
7.4.3 Strong Growth in Emerging Markets
7.4.4 New Healthcare Technologies May enable OTC Approvals
7.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
7.4.6 Self Medication can Reduce the Under Treatment of Disease
7.5 Threats
7.5.1 Competition from Private-Label Brands Will Reduce Profitability
7.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
7.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
7.6 Porter’s Five Forces Analysis of the OTC Pharmaceutical Market
7.6.1 Rivalry Among Competitors [High]
7.6.2 Threat of New Entrants [Medium]
7.6.3 Power of Suppliers [Low]
7.6.4 Power of Buyers [Medium]
7.6.5 Threats of Substitutes [Medium]

8. Conclusions
8.1 The World OTC Pharma Market in 2014-2015
8.1.1 The Leading OTC Product Categories
8.1.2 Leading OTC Pharma Brands, 2015
8.1.3 Leading OTC Manufacturers
8.1.4 Leading National Markets: Emerging Market Represent a Large Proportion
8.1.5 The Global OTC Market Growth Factors
8.1.6 Potential OTC Switching, 2016-2026
8.1.7 Emerging OTC Markets
8.2 Concluding Remarks

Appendices
Visiongain’s Bespoke Research Service
Some Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form

List of Tables
Table 1.1: The World OTC Pharmaceuticals Market Forecast by National Market: Revenue ($bn), AGR (%), and CAGR (%) 2014-2026
Table 2.1 OTC Internal Analgesic Active Ingredients, 2016
Table 2.2 OTC External Analgesic Active Ingredients, 2016
Table 2.3 OTC Cough, Cold and Allergy Active Ingredients, 2016
Table 2.4 OTC Antifungal Active Ingredients, 2016
Table 2.5 OTC Indigestion and Heartburn Active Ingredients, 2016
Table 2.6 OTC Anti-Diarrhoea Active Ingredients, 2016
Table 2.7 OTC Laxative Active Ingredients, 2016
Table 2.8 OTC Dry Eye Syndrome Active Ingredients, 2016
Table 2.9 OTC Bacterial Conjunctivitis Active Ingredients, 2016
Table 2.10 OTC Ocular Allergy Active Ingredients, 2016
Table 2.11 OTC Smoking Cessation Aid Active Ingredients, 2016
Table 3.1 World OTC Pharmaceutical Market Revenue by Product Category: Revenue ($bn) and Market Shares (%), 2015-2016
Table 3.2 Top 10 OTC Pharmaceutical Products: Revenues ($m), 2015
Table 3.3 Top 11 OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2014
Table 3.4 Top 9 OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2015
Table 3.5 World OTC Pharmaceuticals Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 3.6 The World OTC Pharmaceuticals Market Forecast by Product Category: Revenues ($bn), AGR (%), and CAGR (%), 2014-2026
Table 3.7 The World OTC Pharmaceutical Market Forecast by Product Category: CAGR (%) for 2014-2020, 2020-2026 and 2014-2026
Table 3.8 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2014, 2020 and 2026
Table 3.9 The World OTC Pharmaceutical Market Forecast for the Cough, Cold and Allergy Market: Revenue ($bn), AGR (%), and CAGR (%), 2014-2026
Table 3.10 The World OTC Pharmaceutical Market Forecast for the Analgesics Market: Revenue ($bn), AGR (%), and CAGR (%), 2014-2026
Table 3.11 The Gastrointestinals OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026
Table 3.12 The Dermatological OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026
Table 3.13 The Eye Care OTC Pharma Market Forecast: Revenues ($bn), AGR (%), and CAGR (%), 2014-2026
Table 3.14 The Smoking Cessation Aids OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026
Table 3.15 The Other Products OTC Pharma Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2014-2026
Table 4.1 The World OTC Pharmaceutical Market: Revenues ($bn) and Market Shares (%) by Region, 2014
Table 4.2 The World OTC Pharmaceutical Market Forecast: Revenues ($bn), AGR (%), CAGR (%) by Region, 2014-2026
Table 4.3 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2020, 2020-2026 and 2014-2026
Table 4.4 Market Shares (%) of the Leading Regional OTC Pharmaceutical Markets, 2014, 2020 and 2026
Table 4.5 The US OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.6 Selected Leading Companies in the US OTC Pharma Market, 2015
Table 4.7 The Japanese OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.8 Selected Leading Companies in the Japanese OTC Pharma Market, 2015
Table 4.9 The EU5 Market: Revenue ($bn) and Market Share (%) by Region, 2014 and 2015
Table 4.10 The EU5 OTC Pharma Market: Market Shares (%) by National Market, 2014, 2020, 2026
Table 4.11 The EU5 OTC Pharma Market Forecast by Country: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.12 Selected Leading Companies in the EU5 OTC Pharma Market, 2015
Table 4.13 The German OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.14 The UK OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.15 The French OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.16 The Italian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.17 The Spanish OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.18 The Chinese OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.19 Selected Leading Companies in the Chinese OTC Pharma Market, 2015
Table 4.20 The Brazilian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.21 The Russian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.22 The Indian OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.23 The Mexican OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table 4.24 The Rest of the World OTC Pharma Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2014-2026
Table5.1 Selected Leading OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2014
Table 5.2 Selected OTC Pharmaceutical Manufacturers: Revenues ($bn) and Market Shares (%), 2015
Table5.3 GSK: Overview, 2015
Table 5.4 GSK/Novartis OTC Brands, 2015
Table 5.5 GSK Consumer Healthcare: OTC Sales Forecast ($Bb), AGR (%), and CAGR (%), 2015-2026
Table 5.6 Panadol OTC Products, 2016
Table 5.7 Novartis: Voltaren OTC Sales Forecast ($m), AGR (%), and CAGR (%), 2014-2026
Table 5.8 Nicorette OTC Products, 2015
Table 5.9 Bayer: Overview, 2016
Table 5.10 Bayer OTC Brands, 2015
Table 5.11 Bayer: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026
Table 5.12 Bayer Aspirin: OTC Sales Forecast ($m), AGR (%), and CAGR (%), 2016-2026
Table 5.13 Johnson & Johnson Overview, 2016
Table 5.14 Johnson & Johnson OTC Brands, 2016
Table 5.15 Johnson & Johnson: OTC Sales Forecast ($bn), AGR (%), CAGR (%), 2014-2026
Table 5.16 Tylenol OTC Products, 2016
Table 5.17 Nicorette OTC Products, 2016
Table 5.18 Perrigo: Overview, 2016
Table 5.19 Perrigo: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026
Table 5.20 Pfizer: Overview, 2016
Table 5.21 Pfizer OTC Brands, 2016
Table 5.22 Pfizer: OTC Sales Forecast ($Bn), AGR (%), and CAGR (%), 2014-2026
Table 5.23 Advil OTC Brands, 2016
Table 5.24 Procter & Gamble: Overview, 2016
Table 5.25 Reckitt Benckiser: Overview, 2016
Table 5.26 Reckitt Benckiser: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026
Table 5.27 Sanofi: Overview, 2016
Table 5.28 Sanofi OTC Brands, 2016
Table 5.29 Sanofi: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026
Table 5.30 Boehringer Ingelheim: Overview, 2014
Table 5.31 Boehringer Ingelheim OTC Brands, 2016
Table 5.32 Boehringer Ingelheim: OTC Sales Forecast ($bn), AGR (%), and CAGR (%), 2014-2026
Table 6.1 US OTC Switches by Manufacturer, 2002-March 2015
Table 6.2 Potential Cough, Cold and Allergy OTC Switches By Active Ingredient, 2015-2016
Table 6.3 Potential Analgesics OTC Switches by Active Ingredient, 2016-2026
Table 6.4 Potential Gastrointestinals OTC Switches By Active Ingredient, 2016-2026
Table 6.5 Potential Dermatologicals OTC Switches By Active Ingredient, 2016-2025
Table 7.1 SWOT Analysis of the OTC Pharmaceutical Market, 2016

List of Figures
Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets
Figure 2.1 The OTC Pharmaceutical Supply Chain, 2016
Figure 3.1 World OTC Pharmaceutical Market Share(%) of the World Pharmaceutical Market, 2015
Figure 3.2 World OTC Pharmaceutical Market by Product Category: Market Shares(%), 2015
Figure 3.3 The World OTC Pharmaceuticals Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 3.4 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2014-2020
Figure 3.5 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2020-2026
Figure 3.6 The World OTC Pharmaceutical Market by Product Category: CAGR (%), 2014-2026
Figure 3.7 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2020
Figure 3.8 The World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2026
Figure 3.9 Comparison of the World OTC Pharmaceutical Market by Product Category: Market Shares (%), 2014 and 2026
Figure 3.10 The OTC Pharmaceutical Market Forecast for the Cough, Cold and Allergy Market: Revenues ($bn) and AGR (%) 2014-2026
Figure 3.11 The World OTC Pharmaceutical Market Forecast for the Analgesics Market: Revenues ($bn) and AGR (%) 2014-2026
Figure 3.12 The Gastrointestinals OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 3.13 The Dermatological OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 3.14 The Eye Care OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 3.15 The Smoking Cessation Aids OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 3.16 The Other Products OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.1 The World OTC Pharmaceutical Market: Revenues ($bn) by Region,2014
Figure 4.2 The World OTC Pharmaceutical Market: Market Shares (%) by Region,2014
Figure 4.3 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2020
Figure 4.4 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2020-2026
Figure 4.5 Regional OTC Pharmaceutical Market Forecast: CAGR (%), 2014-2026
Figure 4.6 The World OTC Pharmaceutical Market: Market Shares (%) by Region, 2020
Figure 4.7 The World OTC Pharmaceutical Market: Market Shares (%) by Region, 2026
Figure 4.8 The US OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.9 The Japanese OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.10 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2014
Figure 4.11 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2020
Figure 4.12 The EU5 OTC Pharmaceutical Market : Market Shares (%) by National Market, 2026
Figure 4.13 The EU5 OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.14 The German OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.15 The UK OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.16 The French OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.17 The Italian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.18 The Spanish OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.19 The Chinese OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.20 The Brazilian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.21 The Russian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.22 The Indian OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.23 The Mexican OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 4.24 The Rest of the World OTC Pharma Market Forecast: Revenues ($bn) and AGR (%), 2014-2026
Figure 5.1 Selected Leading OTC Pharmaceutical Manufacturers by Market Share (%), 2014
Figure 5.2 Selected OTC Pharmaceutical Manufacturers by Market Share (%), 2015
Figure 5.3 GSK Consumer Healthcare: OTC Sales Forecast ($m), and AGR (%), 2015-2026
Figure 5.4 Novartis: Voltaren OTC Sales Forecast ($m), and AGR (%), 2014-2026
Figure 5.5 Bayer: OTC Sales Forecast ($bn), and AGR (%), 2014-2026
Figure 5.6 Bayer Aspirin: OTC Sales Forecast ($m), and AGR (%), 2014-2026
Figure 5.7 Johnson & Johnson: OTC Sales Forecast ($bn), AGR (%),2014-2026
Figure 5.8 Perrigo: OTC Sales Forecast ($bn), and AGR (%), 2014-2026
Figure 5.9 Pfizer: OTC Sales Forecast ($bn), AGR (%), 2014-2026
Figure 5.10 Reckitt Benckiser: OTC Sales Forecast ($Bn), and AGR (%), 2014-2026
Figure 5.11 Sanofi: OTC Sales Forecast ($bn), and AGR (%), 2014-2026
Figure 5.12 Boehringer Ingelheim: OTC Sales Forecast ($bn), AGR (%), 2014-2026
Figure 6.1 Number of FDA-Approved OTC Switches, By Year, 1976-2014
Figure 6.2 Number of FDA-Approved OTC Switches, By 5-Year Periods, 1976-2014
Figure 7.1 Porter’s Five Analysis of the OTC Pharmaceutical Market , 2016
Figure 8.1 The World OTC Pharmaceutical Market: Market Share (%) by Region, 2014
Figure 8.2 The World OTC Pharmaceutical Market Forecast: Revenue ($bn) and AGR (%), 2014-2026

【レポートのキーワード】

OTC医薬品(市販薬)

★調査レポート[OTC医薬品(市販薬)の世界市場予測2016-2026] ( World OTC Pharmaceutical Market Forecast 2016-2026 / VGAIN6041529) 販売に関する免責事項
[OTC医薬品(市販薬)の世界市場予測2016-2026] ( World OTC Pharmaceutical Market Forecast 2016-2026 / VGAIN6041529) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆